Last update 21 Nov 2024

Forodesine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(1S)-1,4-dideoxy-4-imino-(9-deazahypoxanthin-9-yl)-D-ribitol, 1,4-Dideoxy-4-aza-1-(S)-(9-deazahypoxanthin-9-yl)-D-ribitol, FDS
+ [10]
Target
Mechanism
PNP inhibitors(Purine nucleoside phosphorylase inhibitors), Immunosuppressants
Active Organization
Drug Highest PhaseApproved
First Approval Date
JP (31 Mar 2017),
RegulationOrphan Drug (JP)
Login to view timeline

Structure

Molecular FormulaC11H15ClN4O4
InChIKeyWEIAMZKHBCLFOG-QPAIBFMUSA-N
CAS Registry284490-13-7
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Peripheral T-Cell Lymphoma
JP
31 Mar 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cutaneous T-Cell LymphomaPhase 2
FR
01 Jul 2007
Cutaneous T-Cell LymphomaPhase 2
AU
01 Jul 2007
Cutaneous T-Cell LymphomaPhase 2
DE
01 Jul 2007
Recurrent T Lymphoblastic LymphomaPhase 2
US
01 Jul 2006
Chronic Lymphocytic LeukemiaPhase 2
US
01 Jun 2005
CD19-positive B-cell acute lymphoblastic leukemiaPhase 2
US
01 Sep 2004
Precursor B-Cell Lymphoblastic Leukemia-LymphomaPhase 2
US
01 Sep 2004
T-Cell LeukemiaPhase 2
US
01 Mar 2004
T-Cell LeukemiaPhase 2
GE
01 Mar 2004
CD30-Positive recurrent or refractory Cutaneous T-Cell LymphomaPhase 2
US
01 Feb 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
48
(nxjbqjcaxh) = ejvtfczgak rsshfvdgpk (sqkxdxpcvv, 14 - 38)
Positive
01 Jan 2019
Phase 1/2
44
(jijbeyfdho) = gerexfrouk npddzjgrme (tgmywzfopl, 12.0 - 35.3)
Positive
20 May 2016
Phase 2
144
(dqtjmkgzkd) = oeybqqcuwz unkxgzdhfe (tputrzefvp )
-
01 Sep 2014
Phase 2
8
lvzrfxtsxv(vjcuzfkxvz) = cdfladyohr svnsfayauv (czpgtcdpxc )
-
12 Aug 2010
Not Applicable
64
(gcltjuforz) = tizxjzjmve tvyehhhokh (pilynafnzs )
-
20 May 2009
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free